用镁合金促进兵器装备轻量化

概述了兵器装备轻量化的意义、镁合金的性能特点 ,介绍了镁合金在兵器上应用的实例 ,指出了镁合金在兵器上应用存在的问题 ,分析了镁合金在兵器上应用的前景 ,对镁合金在兵器上的应用工作提出了若干建议     

Food caching in orb-web spiders (Araneae: Araneoidea)

Caching or storing surplus prey may reduce the risk of starvation during periods of food deprivation. While this behaviour occurs in a variety of birds and mammals, it is infrequent among invertebrates. However, golden orb-web spiders, Nephila edulis, incorporate a prey cache in their relatively permanent web, which they feed on during periods of food shortage. Heavier spiders significantly reduced weight loss if they were able to access a cache, but lost weight if the cache was removed. The presence or absence of stored prey had no effect on the weight loss of lighter spiders. Furthermore, N. edulis always attacked new prey, irrespective of the number of unprocessed prey in the web. In contrast, females of Argiope keyserlingi, who build a new web every day and do not cache prey, attacked fewer new prey items if some had already been caught. Thus, a necessary preadaptation to the evolution of prey caching in orb-web spiders may be a durable or permanent web, such as that constructed by Nephila.     

Prenatal diagnosis of chronic granulomatous disease (CGD) in four high risk male fetuses

Prenatal diagnosis of chronic granulomatous disease (CGD) was performed in four male high risk fetuses. The male sex was previously determined by an amniotic cell karyotype. Three kinds of test were performed on fetal blood obtained by umbilical venous puncture under fetoscopy at the 20th gestational week: nitroblue tetrazolium reduction (NBT) cytochemical test with phorbol myristate acetate (PMA) as activator; luminol enhanced chemiluminescence with activation by serum opsonized zymosan (STZ) or PMA; superoxide anion (0) production by measurement of the superoxide dismutase inhibitable reduction of cytochrome c with PMA as activator. Results were compared to those obtained in six fetuses investigated for other inherited diseases. In one case, absence of granulocyte defects was confirmed at birth. In three other cases, the tests showed deficient metabolic oxidative granulocytes. The pregnancy was terminated and the CGD diagnosis was confirmed on the products of abortion. The use of three different techniques performed on whole blood for CGD prenatal diagnosis is recommended instead of a single isolated test to ensure a higher confidence in the diagnosis.     

Determinants of parental decisions to abort for chromosome abnormalities

Parental decisions concerning the continuation of pregnancy following prenatal detection of abnormal chromosomes were evaluated for 80 patients whose diagnosis and prenatal counselling were performed in our centre. Twenty-two anomalies were diagnosed by chorionic villus sampling (CVS) and 58 by amniocentesis. The severity of the chromosome anomaly and associated ultrasound findings in the first vs. second trimester were correlated with patients' decisions. No difference was found in the likelihood of parental decisions to interrupt or continue a pregnancy between CVS and amniocentesis for either the‘severe’ or the‘questionable’ group of chromosome anomalies. Ninety-three per cent of patients with severe prognosis and 27 per cent with questionable prognosis opted for pregnancy termination (p <0·0001). The association of ultrasound anomalies and termination was highly significant (p< 0·001). The severity of the chromosome anomaly, and, to a lesser extent, the visualization of anomalies on ultrasound were the major determinants of parental decisions to terminate the pregnancy. The diagnosis of an anomaly in the first trimester was no more likely ito lead to a termination of pregnancy than in the second trimester.